Multisystem inflammatory syndrome in children and adolescents in Yakutia
https://doi.org/10.25789/YMJ.2021.75.28
Abstract
The observation of ten patients aged from 6 months up to 14 years treated at the Children's Clinical Infectious Diseases Hospital in Yakutsk from September 2020 to March 2021 with the diagnosis U07.2 - Coronavirus infection caused by COVID-19, no virus identified, M30.3 Kawasaki -like syndrome was presented. Among the observed patients, there were no extremely severe ones requiring intensive care, but some children had severe heart damage. All patients were of Yakut nationality. In contrast to current literature data, we did not observe a significant violation of the blood coagulation system, in some patients thrombocytosis was noted. Subarachnoid hemorrhage in one patient was revealed.
About the Authors
T. G. DmitrievaRussian Federation
Dmitrieva Tatyana Gennadievna – Doctor of medicine, professor of pediatrics and children's surgery department
M. A. Togulaeva
Russian Federation
Togulaeva Matrena Afanasievana – deputy chief physician
A. N. Moskvin
Russian Federation
Moskvin Anton Nikolaevich – deputy chief physician
Zh. V. Kozhukhova
Russian Federation
Kozhukhova ZHanna Vitalievna – head of infectious bacterial diagnostic department
G. A. Krichko
Russian Federation
Krichko Galina Aleksandrovna – physician
D. F. Fedorova
Russian Federation
Fedorova Daria Fedorovna – physician
E. V. Mikhailova
Russian Federation
Mikhailova Elena Vladislavovna – student
A. A. Munkhalov
Russian Federation
Munkhalov Alexey Andreevich – student
References
1. Kaleda M.I. Coronavirus disease 2019 (COVID-19) in children: lessons in pediatric rheumatology / M.I. Kaleda, I.P. Nikishina, E.S. Fedorov, E.L. Nasonov // Scientific and practical rheumatology. - 2020.- T. 58, No. 5; P. 469–479.
2. Kantemirova M.G. Children's multisystem inflammatory syndrome associated with a novel coronavirus infection (COVID-19): current information and clinical observation / M.G. Kantemirova, Yu. Yu. Novikova, D.Yu. Ovsyannikov [et al.] // Pediatric Pharmacology. - 2020. - T. 17, No. 3. P. 219-229.
3. L.R. Feldstein, E.B. Rose, S.M. Horwitz, J.P. Collins, M.M. Newhams [et al.] Multisystem Inflammatory Syndrome in U.S. Children and Adolescents //The New England Journal of Medicine. 2020 July 6; DOI: 10.1056/NEJMoa2021680
4. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic //Lancet. 2020 May 23;395(10237):1607-1608. https://doi.org/10.1016/S0140-6736(20)31094-1.
5. World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. https://www.who.int/publications-detail/multisystem-inflammatorysyndrome-in-childrenand-adolescents-with-covid-19
Review
For citations:
Dmitrieva T.G., Togulaeva M.A., Moskvin A.N., Kozhukhova Zh.V., Krichko G.A., Fedorova D.F., Mikhailova E.V., Munkhalov A.A. Multisystem inflammatory syndrome in children and adolescents in Yakutia. Yakut Medical Journal. 2021;(3):111-113. https://doi.org/10.25789/YMJ.2021.75.28